Position in PHVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$25,274,764
+$5,441,795 QoQ
Shares Held
730,907
+4.1% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#21
of 124 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. PHVS ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
939,254 | $349,092,534 | |
| 2 | CELC |
Celcuity Inc.
|
1,704,318 | $178,305,749 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,927,895 | $160,858,551 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
1,843,504 | $72,117,876 | |
| 5 | VCEL |
Vericel Corp
|
1,459,152 | $64,917,672 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
177,517 | $59,430,916 | |
| 7 | GERN |
Geron Corp
|
42,808,659 | $54,795,083 | |
| 8 | ERAS |
Erasca, Inc.
|
2,700,000 | $49,464,000 |
All Filings in PHVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,274,764 | 730,907 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,832,969 | 702,052 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,481,943 | 702,052 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,143,947 | 647,052 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,900,236 | 732,968 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $12,790,036 | 814,652 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,616,878 | 814,652 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,078,089 | 598,169 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,509,284 | 399,430 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,287,932 | 401,901 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,097,957 | 217,396 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,178,758 | 343,975 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,933,366 | 391,900 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,713,729 | 336,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,487,500 | 310,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||